Project Details
Description
A Randomized, Multicenter, Single Blinded, ParallelStudy of the Safety of 100 mg and 200 mg OseltamivirAdministered Intravenously for the Treatment ofInfluenza in Patients Aged 13 Years
| Status | Finished |
|---|---|
| Effective start/end date | 12/28/09 → 12/31/12 |
Funding
- HOFFMANN-LA ROCHE PHARMACEUTICALS